These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 39047881)
1. Qishen granule alleviates doxorubicin-induced cardiotoxicity by suppressing ferroptosis via nuclear erythroid factor 2-related factor 2 (Nrf2) pathway. Xue S; Chen H; Zhang J; Tian R; Xie C; Sun Q; Wang H; Shi T; Guo D; Wang Y; Wang Q J Ethnopharmacol; 2024 Dec; 335():118604. PubMed ID: 39047881 [TBL] [Abstract][Full Text] [Related]
2. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway. Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374 [TBL] [Abstract][Full Text] [Related]
3. Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3. Zhang J; Li W; Xue S; Gao P; Wang H; Chen H; Hong Y; Sun Q; Lu L; Wang Y; Wang Q J Ethnopharmacol; 2024 Jan; 319(Pt 1):117134. PubMed ID: 37714227 [TBL] [Abstract][Full Text] [Related]
4. Fucoidan alleviates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via Nrf2/GPX4 pathway. Wang Y; Han J; Zhan S; Guo C; Yin S; Zhan L; Zhou Q; Liu R; Yan H; Wang X; Yan D Int J Biol Macromol; 2024 Sep; 276(Pt 1):133792. PubMed ID: 38992539 [TBL] [Abstract][Full Text] [Related]
5. Galangin alleviated Doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through GSTP1/JNK pathway. Shu G; Chen K; Li J; Liu B; Chen X; Wang J; Hu X; Lu W; Huang H; Zhang S Phytomedicine; 2024 Nov; 134():155989. PubMed ID: 39217656 [TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy. Lin ZH; Xiang HQ; Yu YW; Xue YJ; Wu C; Lin C; Ji KT FASEB J; 2024 May; 38(10):e23677. PubMed ID: 38775792 [TBL] [Abstract][Full Text] [Related]
7. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling. Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264 [TBL] [Abstract][Full Text] [Related]
8. Licochalcone A alleviates ferroptosis in doxorubicin-induced cardiotoxicity via the PI3K/AKT/MDM2/p53 pathway. Chen G; Luo S; Guo H; Lin J; Xu S Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4247-4262. PubMed ID: 38078919 [TBL] [Abstract][Full Text] [Related]
9. Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis. Li W; Zhang Y; Wang X; Cao J; Qian W; Ling G; Tan N; Jiang J; Sun Q; Li C; Wang W; Wang Y Oxid Med Cell Longev; 2022; 2022():4344677. PubMed ID: 36120600 [TBL] [Abstract][Full Text] [Related]
10. Protective Role of Dioscin against Doxorubicin-Induced Chronic Cardiotoxicity: Insights from Nrf2-GPX4 Axis-Mediated Cardiac Ferroptosis. Liu J; Liu H; Deng L; Wang T; Li L; Chen Y; Qu L; Zou W Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672439 [TBL] [Abstract][Full Text] [Related]
11. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol. Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811 [TBL] [Abstract][Full Text] [Related]
12. Salvia miltiorrhiza suppresses cardiomyocyte ferroptosis after myocardial infarction by activating Nrf2 signaling. Wu YT; Zhang GY; Li L; Liu B; Wang RY; Song RQ; Hua Y; Bi YM; Han X; Zhang F; Wang D; Xie LP; Zhou YC J Ethnopharmacol; 2024 Aug; 330():118214. PubMed ID: 38641076 [TBL] [Abstract][Full Text] [Related]
13. Sarmentosin alleviates doxorubicin-induced cardiotoxicity and ferroptosis Lin Z; Wu C; Song D; Zhu C; Wu B; Wang J; Xue Y Redox Rep; 2024 Dec; 29(1):2392329. PubMed ID: 39150892 [TBL] [Abstract][Full Text] [Related]
14. The Bach1/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice. Wang Y; Qiu J; Yan H; Zhang N; Gao S; Xu N; Wang C; Lou H Arch Toxicol; 2024 Jun; 98(6):1781-1794. PubMed ID: 38573338 [TBL] [Abstract][Full Text] [Related]
15. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway. Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662 [TBL] [Abstract][Full Text] [Related]
16. Aucubin alleviates doxorubicin-induced cardiotoxicity through crosstalk between NRF2 and HIPK2 mediating autophagy and apoptosis. Li W; Cao J; Zhang Y; Ling G; Tan N; Wei Y; Zhang Y; Wang X; Qian W; Jiang J; Zhang J; Wang W; Wang Y Phytomedicine; 2024 May; 127():155473. PubMed ID: 38422972 [TBL] [Abstract][Full Text] [Related]
17. Role of ferroptosis in promoting cardiotoxicity induced by Imatinib Mesylate via down-regulating Nrf2 pathways in vitro and in vivo. Song C; Li D; Zhang J; Zhao X Toxicol Appl Pharmacol; 2022 Jan; 435():115852. PubMed ID: 34973290 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin. Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936 [TBL] [Abstract][Full Text] [Related]
19. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway. Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624 [TBL] [Abstract][Full Text] [Related]
20. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation. Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]